Facebook
Twitter
Telegram
Report an ErrorNeurocrine Biosciences Balance Sheet 2011-2024 | NBIX
Annual Balance Sheet Neurocrine Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
39.2 M | -152 M | -8.9 M | -389 M | 383 M | 756 M | 376 M | -83.3 M | -74.2 M | -31 M | -44.8 M | -63.8 M | -50.1 M |
Long Term Debt |
258 M | 93.5 M | 335 M | 318 M | - | 388 M | 370 M | - | - | - | - | - | - |
Long Term Debt Current |
32 M | 17.4 M | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 104 M | 424 M | 391 M | 19.8 M | 24.6 M | 18.7 M | 22.6 M | 26 M | 31.2 M |
Total Current Liabilities |
655 M | 538 M | 246 M | 186 M | 565 M | 88.2 M | 54.4 M | 30.4 M | 25.7 M | 15.7 M | 11.7 M | 15.6 M | 47.1 M |
Total Liabilities |
1.02 B | 661 M | 698 M | 608 M | 669 M | 512 M | 445 M | 50.2 M | 50.3 M | 34.3 M | 34.3 M | 41.6 M | 78.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 2.92 M | 37.3 M |
Retained Earnings |
-157 M | -407 M | -636 M | - | -1.13 B | -1.18 B | -1.2 B | -1.06 B | -915 M | -826 M | -766 M | -720 M | -725 M |
Total Assets |
3.25 B | 2.37 B | 2.07 B | 1.73 B | 1.31 B | 993 M | 818 M | 365 M | 475 M | 243 M | 155 M | 196 M | 138 M |
Cash and Cash Equivalents |
251 M | 263 M | 344 M | 190 M | 112 M | 142 M | 255 M | 83.3 M | 74.2 M | 31 M | 44.8 M | 63.8 M | 50.1 M |
Book Value |
2.23 B | 1.71 B | 1.37 B | 1.13 B | 637 M | 481 M | 372 M | 315 M | 424 M | 209 M | 120 M | 154 M | 60.1 M |
Total Shareholders Equity |
2.23 B | 1.71 B | 1.37 B | 1.13 B | 637 M | 481 M | 372 M | 315 M | 424 M | 209 M | 120 M | 154 M | 60.1 M |
All numbers in USD currency
Quarterly Balance Sheet Neurocrine Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
253 M | 258 M | 85.9 M | 89.1 M | 170 M | 93.5 M | - | - | 378 M | 335 M | 331 M | 326 M | 322 M | 318 M | 318 M | 318 M | 318 M | - | 409 M | 409 M | 409 M | 388 M | 388 M | 388 M | 388 M | 370 M | 370 M | 370 M | 370 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.09 B | 1.02 B | 846 M | 760 M | 675 M | 661 M | 599 M | - | 753 M | 698 M | 671 M | 677 M | 641 M | 608 M | 608 M | 608 M | 608 M | 669 M | 669 M | 669 M | 669 M | 512 M | 512 M | 512 M | 512 M | 445 M | 445 M | 445 M | 445 M | 50.2 M | 50.2 M | 50.2 M | 50.2 M | 50.3 M | 50.3 M | 50.3 M | 50.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 34.3 M | 41.6 M | 41.6 M | 41.6 M | 41.6 M | 78.3 M | 78.3 M | 78.3 M | 78.3 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 730 K | 1.46 M | 2.19 M | 2.92 M | 2.92 M | 2.92 M | 2.92 M | 34.2 M | 34.2 M | 34.2 M | 34.2 M |
Retained Earnings |
-114 M | -157 M | -305 M | -388 M | -483 M | -407 M | -496 M | - | -547 M | -636 M | -628 M | -651 M | -693 M | -725 M | -725 M | -725 M | -725 M | -1.13 B | -1.13 B | -1.13 B | -1.13 B | -1.18 B | -1.18 B | -1.18 B | -1.18 B | -1.2 B | -1.2 B | -1.2 B | -1.2 B | -1.06 B | -1.06 B | -1.06 B | -1.06 B | -915 M | -915 M | -915 M | -915 M | -826 M | -826 M | -826 M | -826 M | -766 M | -766 M | -766 M | -766 M | -720 M | -720 M | -720 M | -720 M | -725 M | -725 M | -725 M | -725 M |
Total Assets |
3.47 B | 3.25 B | 2.85 B | 2.61 B | 2.36 B | 2.37 B | 2.14 B | - | 2.14 B | 2.07 B | 2.02 B | 1.96 B | 1.85 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 1.31 B | 1.31 B | 1.31 B | 1.31 B | 993 M | 993 M | 993 M | 993 M | 818 M | 818 M | 818 M | 818 M | 365 M | 365 M | 365 M | 365 M | 475 M | 475 M | 475 M | 475 M | 243 M | 243 M | 243 M | 243 M | 155 M | 155 M | 155 M | 155 M | 196 M | 196 M | 196 M | 196 M | 138 M | 138 M | 138 M | 138 M |
Cash and Cash Equivalents |
396 M | 251 M | 294 M | 160 M | 104 M | 263 M | 212 M | 163 M | 270 M | 341 M | 311 M | 368 M | 353 M | 187 M | 187 M | 187 M | 187 M | 112 M | 112 M | 112 M | 112 M | 142 M | 142 M | 142 M | 142 M | 255 M | 255 M | 255 M | 255 M | 83.3 M | 83.3 M | 83.3 M | 83.3 M | 74.2 M | 74.2 M | 74.2 M | 74.2 M | 31 M | 31 M | 31 M | 31 M | 44.8 M | 44.8 M | 44.8 M | 44.8 M | 63.8 M | 63.8 M | 63.8 M | 63.8 M | 50.1 M | 50.1 M | 50.1 M | 50.1 M |
Book Value |
2.39 B | 2.23 B | 2 B | 1.85 B | 1.68 B | 1.71 B | 1.54 B | - | 1.39 B | 1.37 B | 1.35 B | 1.28 B | 1.21 B | 1.13 B | 1.13 B | 1.13 B | 1.13 B | 637 M | 637 M | 637 M | 637 M | 481 M | 481 M | 481 M | 481 M | 372 M | 372 M | 372 M | 372 M | 315 M | 315 M | 315 M | 315 M | 424 M | 424 M | 424 M | 424 M | 209 M | 209 M | 209 M | 209 M | 120 M | 120 M | 120 M | 120 M | 154 M | 154 M | 154 M | 154 M | 60.1 M | 60.1 M | 60.1 M | 60.1 M |
Total Shareholders Equity |
2.39 B | 2.23 B | 2 B | 1.85 B | 1.68 B | 1.71 B | 1.54 B | 1.42 B | 1.39 B | 1.37 B | 1.35 B | 1.28 B | 1.21 B | 1.13 B | 1.13 B | 1.13 B | 1.13 B | 637 M | 637 M | 637 M | 637 M | 481 M | 481 M | 481 M | 481 M | 372 M | 372 M | 372 M | 372 M | 315 M | 315 M | 315 M | 315 M | 424 M | 424 M | 424 M | 424 M | 209 M | 209 M | 209 M | 209 M | 120 M | 120 M | 120 M | 120 M | 154 M | 154 M | 154 M | 154 M | 60.1 M | 60.1 M | 60.1 M | 60.1 M |
All numbers in USD currency